Table 1.
Baseline characteristics of participants completing 8 weeks of the trial, by randomization group. Data used in the per-protocol analysis of individuals completing the week-8 ACT.
| Characteristics | Intervention (n=67) | Control (n=85) | All (n=152) | |
| Age (years), mean (SD) | 35.73 (11.48) | 36.62 (13.23) | 36.23 (12.45) | |
| Sex, n (%) | ||||
|
|
Female | 52 (77.6) | 70 (82.4) | 122 (80.3) |
|
|
Male | 13 (19.4) | 13 (15.3) | 26 (17.1) |
|
|
Other | 2 (3) | 2 (2.4) | 4 (2.6) |
| Asthma duration, n (%) | ||||
|
|
<1 month | 1 (1.5) | 1 (1.2) | 2 (1.3) |
|
|
1 to <3 months | 2 (3) | 2 (2.4) | 4 (2.6) |
|
|
3 months to <1 year | 2 (3) | 4 (4.7) | 6 (4) |
|
|
1 year to <2 years | 4 (6) | 5 (5.9) | 9 (5.9) |
|
|
2 years to <5 years | 11 (16.4) | 5 (5.9) | 16 (10.5) |
|
|
>5 years | 47 (70.2) | 68 (80) | 115 (75.7) |
| Physician contact, n (%) | ||||
|
|
Regular | 22 (32.8) | 30 (35.3) | 52 (34.2) |
|
|
Occasional | 42 (62.7) | 40 (47.1) | 82 (54) |
|
|
Not anymore | 3 (4.5) | 10 (11.9) | 13 (8.6) |
|
|
Never | 0 (0) | 5 (5.9) | 5 (3.3) |
| Diagnosed by a physician, n (%) | ||||
|
|
Yes | 67 (100) | 81 (95.3) | 148 (97.4) |
|
|
No | 0 (0) | 4 (4.7) | 4 (2.6) |
| ACTa total score, mean (SD) | 12.60 (4.10) | 13.04 (3.93) | 12.84 (4.00) | |
| SF-12 physical health subscaleb, mean (SD) | 39.28 (8.95) | 39.86 (9.04) | 39.61 (8.98) | |
| SF-12 mental health subscalec, mean (SD) | 38.35 (9.84) | 37.74 (10.74) | 38.01 (10.32) | |
aACT: Asthma Control Test (possible range 5-25).
bSF-12 physical health subscale: Short-Form Health Survey-12 physical health subscale (possible range 0-100).
cSF-12 mental health subscale: Short-Form Health Survey-12 mental health subscale (possible range 0-100).